Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 4175-4177, September 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narita, T.
Right arrow Articles by Kudo, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narita, T.
Right arrow Articles by Kudo, H.

Effect of Melatonin on B16 Melanoma Growth in Athymic Mice

Takeo Narita1 and Hajime Kudo

Second Department of Pathology, Hirosaki University School of Medicine, Hirosaki, 036 Japan

The effect of melatonin on the growth of B16 mice melanoma was examined. Male and female BALB/c athymic mice, inoculated with 7 x 104 melanoma cells, were given drinking water containing melatonin (5 µg/g body weight/day) and 0.5% ethanol. Compared to control animals the melatonin treated male and female athymic mice had significantly smaller tumors on Day 40. The weights of the testes, the ovaries, and the adrenal glands of melatonin treated mice were significantly reduced compared to control animals. These data indicate that melatonin p.o. Significantly inhibited the growth of B16 mouse melanoma and that the antitumor effect of melatonin was associated with a significant decrease in gonadal and adrenal weights.

1 To whom requests for reprints should be addressed.

Received 11/ 8/84. Revised 5/22/85. Accepted 5/29/85.




This article has been cited by other articles:


Home page
Integr Cancer TherHome page
M. Uzick
Naturopathic Approaches
Integr Cancer Ther, September 1, 2005; 4(3): 253 - 258.
[PDF]


Home page
Am J EpidemiolHome page
J. Kliukiene, T. Tynes, and A. Andersen
Residential and Occupational Exposures to 50-Hz Magnetic Fields and Breast Cancer in Women: A Population-based Study
Am. J. Epidemiol., May 1, 2004; 159(9): 852 - 861.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman
Melatonin: From Basic Research to Cancer Treatment Clinics
J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.